Allocate Software PLC Grant of Share Options to Directors (1128K)
August 15 2012 - 10:35AM
UK Regulatory
TIDMALL
RNS Number : 1128K
Allocate Software PLC
15 August 2012
15 August 2012
ALLOCATE SOFTWARE PLC
("Allocate" or "the Company")
Grant of Share Options to Directors
The Company has today granted an award of share options under
the Company's Unapproved and CSOP option schemes to each of the
following Directors to acquire ordinary shares of 5p each in the
Company at a strike price of 71.5p per share as detailed below. The
options are exercisable from 15 August 2015.
Director New share options Total number of share
awarded options held
Allen Swann 200,000 700,000
Chris Gale 200,000 700,000
Enquiries:
Allocate Software plc Tel: +44 (0) 20 7355 5555
Chris Gale - Chief Financial Officer
Numis Securities Tel: +44 (0) 20 7260 1000
Nominated adviser - Michael Meade /
Richard Thomas
Corporate Broking - James Black
Gable Communications Tel: +44 (0) 20 7193 7463
Justine James +44 (0) 7525 324 431
About Allocate Software plc
Allocate Software plc is the leading workforce optimisation
software applications provider for world-wide organisations with
large, multi-skilled workforces. With a blue chip client base
spanning the public and private sector, its key vertical markets
include: Healthcare and Defence.
At the core of the business is Allocate's workforce optimisation
software, which organisations use to deploy the right people with
the right skills, to the right place at the right time.
Headquartered in London, Allocate provides services and support to
its increasing international customer base through regional offices
in the UK, Sweden, USA, Australia and Malaysia.
Allocate is quoted on the London Stock Exchange (AIM: ALL). For
further information please visit www.allocatesoftware.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBKPDNPBKDQFD
Atlantic Lithium (LSE:ALL)
Historical Stock Chart
From Jan 2025 to Feb 2025
Atlantic Lithium (LSE:ALL)
Historical Stock Chart
From Feb 2024 to Feb 2025